ElectroCore +$0.72 +8.07% Today
1D 1W 1M 3M 1Y 5Y
14 Nov Expected
This list is based on the watchlists of people on Stock Events who follow ECOR. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Axonics, Inc. competes in the neuromodulation market, offering products that could be seen as alternatives to ElectroCore's non-invasive vagus nerve stimulation devices.
LivaNova PLC operates in the same space of neuromodulation, providing therapies that could directly compete with ElectroCore's solutions for epilepsy and other neurological conditions. Inspire Medical Systems
INSP
Mkt Cap 5.36B
Inspire Medical Systems, Inc. offers innovative obstructive sleep apnea treatments using nerve stimulation, a direct competitor to ElectroCore's nerve stimulation therapies.
Neogen Corporation, while primarily focused on food and animal safety, has divisions that explore bioelectronic medicine, potentially overlapping with ElectroCore's market. Boston Scientific
BSX
Mkt Cap 120.45B
Boston Scientific Corporation offers a wide range of medical devices, including neuromodulation products that could serve as alternatives to ElectroCore's technology.
AbbVie Inc., through its acquisition of Allergan, has entered the neuromodulation market, potentially competing with ElectroCore's offerings. Medtronic
MDT
Mkt Cap 113.61B
Medtronic PLC provides a broad array of medical devices, including those for neuromodulation, directly competing with ElectroCore's nerve stimulation devices. Smith & Nephew
SNN
Mkt Cap 13.45B
Smith & Nephew plc, while mainly focused on orthopedics, has started exploring the bioelectronic medicine space, which could put it in competition with ElectroCore.
Stryker Corporation's medical technologies, including neurotechnology and spine products, could indirectly compete with ElectroCore by offering different solutions for similar conditions. Health Technology
Medical Specialties
Manufacturing
Electromedical and Electrotherapeutic Apparatus Manufacturing
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Show more...